VanEck Associates’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.42M | Buy |
|
|||||
|
2025
Q2 | $4.04M | Hold |
|
|||||
|
2025
Q1 | $2.83M | Hold |
|
|||||
|
2024
Q4 | $3.27M | Buy |
|
|||||
|
2024
Q3 | $71K | Sell |
|
|||||
|
2024
Q2 | $4.31M | Buy |
|
|||||
|
2024
Q1 | $4.9M | Buy |
|
|||||
|
2023
Q4 | $4.25M | Sell |
|
|||||
|
2023
Q3 | $3.31M | Sell |
|
|||||
|
2023
Q2 | $4.31M | Sell |
|
|||||
|
2023
Q1 | $3.74M | Sell |
|
|||||
|
2022
Q4 | $3.79M | Buy |
|
|||||
|
2022
Q3 | $5.18M | Sell |
|
|||||
|
2022
Q2 | $7.67M | Buy |
|
|||||
|
2022
Q1 | $7.16M | Buy |
|
|||||
|
2021
Q4 | $7.88M | Buy |
|
|||||
|
2021
Q3 | $10.8M | Sell |
|
|||||
|
2021
Q2 | $16.9M | Sell |
|
|||||
|
2021
Q1 | $14.5M | Buy |
|